Negative and Cognitive Symptoms A Focus on Digital Therapeutics

Negative and cognitive symptoms are significant challenges for individuals living with schizophrenia, impacting their functional outcomes and requiring clinical attention. Despite their high clinical relevance, there are currently no approved treatments specifically targeting these symptoms. However, advancements in digital therapeutics (DTx) offer promising avenues for managing these aspects of schizophrenia. In this video, we explore the role of prescription digital therapeutics (PDTs) in addressing negative and cognitive symptoms. Learn about how these software-based treatments are rigorously evaluated for safety and effectiveness, developed under Good Manufacturing Practice, and may even qualify for reimbursement. Join us as we delve into the potential of DTx to improve the lives of those affected by schizophrenia.